🍽️ vitamin k2

AI Engines For more Details: PerplexityKagi LabsYou

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations    |     πŸ“ Dosage Seen

Data Contradictions β€” Limits of Certainity

Impacted of vitamin k2 On Probiotics

Rank Probiotic Impact

Bacteria Impacted by vitamin k2

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

πŸ§™?

Taxonomy Rank Effect Citations Notation
Eggerthellaceae family Increases 👪 Source Study
Coriobacteriaceae family Increases 📓 Source Study Associated with Iron Deficiency (Low)
Collinsella genus Increases 👶 Source Study proinflammatory
Coriobacterium genus Increases 👶 Source Study
Enorma genus Increases 👶 Source Study
Olegusella genus Increases 👶 Source Study
Parvibacter genus Increases 👶 Source Study
Senegalimassilia genus Increases 👶 Source Study
Adlercreutzia genus Increases 👪 Source Study
Adlercreutzia genus Increases 📓 Source Study
environmental samples no rank Increases 👶 Source Study
environmental samples no rank Increases 👶 Source Study
unclassified Adlercreutzia no rank Increases 👶 Source Study
unclassified Coriobacteriaceae no rank Increases 👶 Source Study
Coriobacteriales order Increases 👪 Source Study
[Collinsella] massiliensis species Increases ⚗️ Source Study
Adlercreutzia caecimuris species Increases 👶 Source Study
Adlercreutzia equolifaciens species Increases 👶 Source Study
Adlercreutzia hattorii species Increases 👶 Source Study
Adlercreutzia mucosicola species Increases 👶 Source Study
Adlercreutzia muris species Increases 👶 Source Study
Adlercreutzia sp. species Increases 👶 Source Study
Parvibacter caecicola species Increases ⚗️ Source Study
Adlercreutzia equolifaciens species Increases 📓 Source Study
Adlercreutzia equolifaciens DSM 19450 strain Increases 👶 Source Study
Adlercreutzia equolifaciens subsp. celatus subspecies Increases 👶 Source Study
Adlercreutzia equolifaciens subsp. equolifaciens subspecies Increases 👶 Source Study

Impact of vitamin k2 on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Allergies 0.4 -0.4
Alopecia (Hair Loss) 0.5 -0.5
Alzheimer's disease 0.4 0.6 -0.5
Ankylosing spondylitis 0.2 -0.2
Atherosclerosis 0.2 -0.2
Atrial fibrillation 0.2 -0.2
Autism 0.2 -0.2
Barrett esophagus cancer 0.6 -0.6
Brain Trauma 0.2 -0.2
Breast Cancer 0.3 0.3
Carcinoma 0.6 0.6 0
Celiac Disease 0.2 0.2
Chronic Kidney Disease 0.2 0.2
Colorectal Cancer 0.2 0.2
Constipation 0.3 0.3
Coronary artery disease 0.2 -0.2
COVID-19 1.2 1.2
Crohn's Disease 0.2 0.6 -2
Depression 0.2 0.2 0
Endometriosis 0.6 -0.6
Epilepsy 0.2 -0.2
erectile dysfunction 0.2 -0.2
Functional constipation / chronic idiopathic constipation 0.3 0.3
Graves' disease 0.2 1.1 -4.5
hypercholesterolemia (High Cholesterol) 0.6 -0.6
hyperglycemia 0.6 -0.6
Hyperlipidemia (High Blood Fats) 0.2 0.2 0
hypersomnia 0.3 0.3
hypertension (High Blood Pressure 0.6 -0.6
Inflammatory Bowel Disease 0.6 0.2 2
Intelligence 0.6 0.6
Intracranial aneurysms 0.2 0.2
Liver Cirrhosis 0.4 -0.4
Long COVID 1.3 1.8 -0.38
Metabolic Syndrome 1.3 -1.3
Mood Disorders 0.6 0.4 0.5
Multiple Sclerosis 0.4 0.4
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 0.2 -0.2
Obesity 0.2 1.3 -5.5
pancreatic cancer 0.2 0.2
Parkinson's Disease 0.6 -0.6
Premenstrual dysphoric disorder 0.2 -0.2
primary biliary cholangitis 0.2 0.3 -0.5
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 0.2 0.2 0
Schizophrenia 0.4 0.2 1
Stress / posttraumatic stress disorder 0.8 0.6 0.33
Tic Disorder 0.2 0.2
Type 2 Diabetes 1.3 -1.3
Ulcerative colitis 0.8 0.3 1.67
Unhealthy Ageing 0.6 0.6

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)